Researchers using CRISPR/Cas9 technology have recognized novel genes for cancer treatment such as suppression of NAD kinase (NADK activates pentose phosphate pathway involved in cancer survival) or ketohexokinase (KHK suppression leads to elevated fructose metabolites intricate in liver cancer progression) and inhibit tumor growth (245). This evidence concerns the gene NADK and neoplasm.